W. K. Steagall

Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis

Jianhua Yao, Joel Moss, Nilo A. Avila, 2019, Chest.

Functional Genomics of Lung Disease

S. Redline, N. Friedman, A. Regev, 2004 .

Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.

J. Moss, M. Moses, Connie G. Glasgow, 2010, Respiratory medicine.

ADP-ribosyltransferase-specific Modification of Human Neutrophil Peptide-1*

J. Moss, R. Levine, W. K. Steagall, 2006, Journal of Biological Chemistry.

CA‐125 in Disease Progression and Treatment of Lymphangioleiomyomatosis

J. Moss, M. Stylianou, Connie G. Glasgow, 2017, Chest.

Genetic heterogeneity of circulating cells from patients with lymphangioleiomyomatosis with and without lung transplantation.

J. Moss, Xiong Cai, W. K. Steagall, 2015, American journal of respiratory and critical care medicine.

Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome.

M. Raffeld, S. Holland, J. Moss, 2008, American journal of respiratory and critical care medicine.

Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation.

E. Henske, J. Moss, M. Stylianou, 2017, Cancer research.